Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Pharmacol
2015 Nov 01;885:881-93. doi: 10.1124/mol.115.100982.
Show Gene links
Show Anatomy links
α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells.
Hone AJ
,
McIntosh JM
,
Azam L
,
Lindstrom J
,
Lucero L
,
Whiteaker P
,
Passas J
,
Blázquez J
,
Albillos A
.
???displayArticle.abstract???
Ligands that selectively inhibit human α3β2 and α6β2 nicotinic acetylcholine receptor (nAChRs) and not the closely related α3β4 and α6β4 subtypes are lacking. Current α-conotoxins (α-Ctxs) that discriminate among these nAChR subtypes in rat fail to discriminate among the human receptor homologs. In this study, we describe the development of α-Ctx LvIA(N9R,V10A) that is 3000-fold more potent on oocyte-expressed human α3β2 than α3β4 and 165-fold more potent on human α6/α3β2β3 than α6/α3β4 nAChRs. This analog was used in conjuction with three other α-Ctx analogs and patch-clamp electrophysiology to characterize the nAChR subtypes expressed by human adrenal chromaffin cells. LvIA(N9R,V10A) showed little effect on the acetylcholine-evoked currents in these cells at concentrations expected to inhibit nAChRs with β2 ligand-binding sites. In contrast, the β4-selective α-Ctx BuIA(T5A,P6O) inhibited >98% of the acetylcholine-evoked current, indicating that most of the heteromeric receptors contained β4 ligand-binding sites. Additional studies using the α6-selective α-Ctx PeIA(A7V,S9H,V10A,N11R,E14A) indicated that the predominant heteromeric nAChR expressed by human adrenal chromaffin cells is the α3β4* subtype (asterisk indicates the possible presence of additional subunits). This conclusion was supported by polymerase chain reaction experiments of human adrenal medulla gland and of cultured human adrenal chromaffin cells that demonstrated prominent expression of RNAs for α3, α5, α7, β2, and β4 subunits and a low abundance of RNAs for α2, α4, α6, and α10 subunits.
,
Correction to "α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells".
2016, Pubmed
,
Correction to "α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells".
2016,
Pubmed
Albuquerque,
Mammalian nicotinic acetylcholine receptors: from structure to function.
2009,
Pubmed
Andersen,
Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets.
2004,
Pubmed
Azam,
α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6ß4 and α6ß2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release.
2010,
Pubmed
,
Xenbase
Azam,
Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes.
2006,
Pubmed
Azam,
Amino acid residues that confer high selectivity of the alpha6 nicotinic acetylcholine receptor subunit to alpha-conotoxin MII[S4A,E11A,L15A].
2008,
Pubmed
,
Xenbase
Beissner,
Efficient binding of 4/7 α-conotoxins to nicotinic α4β2 receptors is prevented by Arg185 and Pro195 in the α4 subunit.
2012,
Pubmed
,
Xenbase
Brown,
Nicotinic alpha5 subunit deletion locally reduces high-affinity agonist activation without altering nicotinic receptor numbers.
2007,
Pubmed
Campos-Caro,
Neuronal nicotinic acetylcholine receptors on bovine chromaffin cells: cloning, expression, and genomic organization of receptor subunits.
1997,
Pubmed
,
Xenbase
Carlisle,
Nicotine signals through muscle-type and neuronal nicotinic acetylcholine receptors in both human bronchial epithelial cells and airway fibroblasts.
2004,
Pubmed
Cartier,
A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors.
1996,
Pubmed
,
Xenbase
Criado,
Differential expression of alpha-bungarotoxin-sensitive neuronal nicotinic receptors in adrenergic chromaffin cells: a role for transcription factor Egr-1.
1997,
Pubmed
Di Angelantonio,
Molecular biology and electrophysiology of neuronal nicotinic receptors of rat chromaffin cells.
2003,
Pubmed
Everhart,
Identification of residues that confer alpha-conotoxin-PnIA sensitivity on the alpha 3 subunit of neuronal nicotinic acetylcholine receptors.
2003,
Pubmed
,
Xenbase
Gahring,
Nicotinic receptor Alpha7 expression during mouse adrenal gland development.
2014,
Pubmed
George,
Function of human α3β4α5 nicotinic acetylcholine receptors is reduced by the α5(D398N) variant.
2012,
Pubmed
,
Xenbase
Gerzanich,
alpha 5 Subunit alters desensitization, pharmacology, Ca++ permeability and Ca++ modulation of human neuronal alpha 3 nicotinic receptors.
1998,
Pubmed
,
Xenbase
Gotti,
Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion.
2005,
Pubmed
Grady,
Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release.
2009,
Pubmed
Groebe,
alpha-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors.
1995,
Pubmed
Hernández-Vivanco,
Monkey adrenal chromaffin cells express α6β4* nicotinic acetylcholine receptors.
2014,
Pubmed
Hone,
Nicotinic acetylcholine receptors in dorsal root ganglion neurons include the α6β4* subtype.
2012,
Pubmed
Hone,
Positional scanning mutagenesis of α-conotoxin PeIA identifies critical residues that confer potency and selectivity for α6/α3β2β3 and α3β2 nicotinic acetylcholine receptors.
2013,
Pubmed
,
Xenbase
Hone,
A novel fluorescent alpha-conotoxin for the study of alpha7 nicotinic acetylcholine receptors.
2009,
Pubmed
,
Xenbase
Hone,
α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.
2012,
Pubmed
,
Xenbase
Innocent,
Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors.
2008,
Pubmed
,
Xenbase
Jacobsen,
Critical residues influence the affinity and selectivity of alpha-conotoxin MI for nicotinic acetylcholine receptors.
1999,
Pubmed
,
Xenbase
Kim,
α6 nAChR subunit residues that confer α-conotoxin BuIA selectivity.
2012,
Pubmed
,
Xenbase
Kuryatov,
Human alpha6 AChR subtypes: subunit composition, assembly, and pharmacological responses.
2000,
Pubmed
,
Xenbase
Kuryatov,
Expression of functional human α6β2β3* acetylcholine receptors in Xenopus laevis oocytes achieved through subunit chimeras and concatamers.
2011,
Pubmed
,
Xenbase
Kurzen,
Phenotypical and molecular profiling of the extraneuronal cholinergic system of the skin.
2004,
Pubmed
Ley,
Efficient expression of functional (α6β2)2β3 AChRs in Xenopus oocytes from free subunits using slightly modified α6 subunits.
2014,
Pubmed
,
Xenbase
Lips,
Nicotinic acetylcholine receptors in rat and human placenta.
2005,
Pubmed
Liu,
Functional α7β2 nicotinic acetylcholine receptors expressed in hippocampal interneurons exhibit high sensitivity to pathological level of amyloid β peptides.
2012,
Pubmed
Liu,
A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides.
2009,
Pubmed
,
Xenbase
Liu,
Nicotinic acetylcholine receptor subunits in rhesus monkey retina.
2009,
Pubmed
Livak,
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
2001,
Pubmed
Lomazzo,
Quantitative analysis of the heteromeric neuronal nicotinic receptors in the rat hippocampus.
2010,
Pubmed
Luo,
A novel α4/7-conotoxin LvIA from Conus lividus that selectively blocks α3β2 vs. α6/α3β2β3 nicotinic acetylcholine receptors.
2014,
Pubmed
,
Xenbase
Luo,
alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release.
1998,
Pubmed
,
Xenbase
Luo,
Single-residue alteration in alpha-conotoxin PnIA switches its nAChR subtype selectivity.
1999,
Pubmed
,
Xenbase
Luo,
Characterization of a novel α-conotoxin from conus textile that selectively targets α6/α3β2β3 nicotinic acetylcholine receptors.
2013,
Pubmed
,
Xenbase
Marks,
Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain.
2011,
Pubmed
McIntosh,
Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors.
2004,
Pubmed
,
Xenbase
Mikulski,
Nicotinic receptors on rat alveolar macrophages dampen ATP-induced increase in cytosolic calcium concentration.
2010,
Pubmed
Mollard,
Activation of nicotinic receptors triggers exocytosis from bovine chromaffin cells in the absence of membrane depolarization.
1995,
Pubmed
Moretti,
The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization.
2014,
Pubmed
,
Xenbase
Peng,
Characterization of the human nicotinic acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) and alpha (alpha) 10 (CHRNA10) in lymphocytes.
2004,
Pubmed
Pfaffl,
Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper--Excel-based tool using pair-wise correlations.
2004,
Pubmed
Pérez-Alvarez,
Pharmacological characterization of native α7 nicotinic ACh receptors and their contribution to depolarization-elicited exocytosis in human chromaffin cells.
2012,
Pubmed
Pérez-Alvarez,
Native α6β4* nicotinic receptors control exocytosis in human chromaffin cells of the adrenal gland.
2012,
Pubmed
Quik,
Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA.
2005,
Pubmed
Sciaccaluga,
Crucial role of nicotinic α5 subunit variants for Ca2+ fluxes in ventral midbrain neurons.
2015,
Pubmed
Silver,
Selection of housekeeping genes for gene expression studies in human reticulocytes using real-time PCR.
2006,
Pubmed
Sine,
Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of determinants of alpha-conotoxin M1 selectivity.
1995,
Pubmed
Smith,
Comparative functional expression of nAChR subtypes in rodent DRG neurons.
2013,
Pubmed
Talley,
Alpha-conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as alpha3beta2 and alpha7 nicotinic acetylcholine receptors.
2006,
Pubmed
,
Xenbase
Teichert,
A uniquely selective inhibitor of the mammalian fetal neuromuscular nicotinic acetylcholine receptor.
2005,
Pubmed
,
Xenbase
Turner,
Nicotinic cholinergic receptors in the rat cerebellum: multiple heteromeric subtypes.
2005,
Pubmed
Vandesompele,
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.
2002,
Pubmed
West,
Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells.
2003,
Pubmed
Whiteaker,
Pharmacological and immunochemical characterization of alpha2* nicotinic acetylcholine receptors (nAChRs) in mouse brain.
2009,
Pubmed
Whiteaker,
Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist.
2007,
Pubmed
,
Xenbase
Whiteaker,
Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine.
2000,
Pubmed
